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A B S T R A C T
Purpose: Status epilepticus (SE) has attracted renewed interest lately, and efforts are made to optimize
every treatment stage. For refractory SE, optimal supporting care involves mechanical ventilation and
intensive care unit (ICU) admission. Infections often complicate SE and recently a single-centre
observational study demonstrated an association between infections and poor short-term outcome of SE
in a cohort of severely ill patients. We have here attempted to replicate those ﬁndings in a different
cohort.
Method: We performed a retrospective observational study and included all patients with a diagnosis of
SE during 2008–2012 at a Swedish tertiary referral centre.
Results: The cohort consisted of 103 patients (53% female, 47% male, median age 62 years, range 19–87
years). In house mortality was less than 2 and 70% of the patients’ were discharged home. The most
common aetiologies of SE were uncontrolled epilepsy (37%) and brain tumours (16%). A total of 39
patients suffered infections during their stay. Presence of infection was associated with mechanical
ventilation (OR 3.344, 95% CI 1.44–7.79) as well as not being discharged home (OR2.705, 95% CI 1.14–
6.44), and duration of SE was signiﬁcantly longer in patients with infection (median 1 day vs. 2.5 days,
p < 0.001).
Conclusion: We conclude that the previously described association between infections, a longer SE
duration, and an unfavourable outcome of SE seems valid also in SE of less severe aetiology.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) is a neurological emergency requiring
rapid treatment. Over the last years, SE has attracted renewed
interest and several studies have addressed important aspects of
initial management, particularly ﬁrst- or second-line antiepileptic
medication.1–3 In addition to the efforts concerning early
management of SE, there is also substantial interest in the
management of patients that fail to respond to initial treatment.
There is little evidence from randomized trials to guide clinicians in
this scenario, but fundamental to all treatment strategies is
optimal supporting care pending resolution of seizure activity.4–7
SE is frequently complicated by infections, which can be present
either at onset of SE or are acquired during hospital stay. The risk of
nosocomial infection is probably enhanced in medically refractory
cases of SE, since such patients are often in need of general* Corresponding author. Tel.: +46 186110000.
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complications.6
In a recent study, Sutter et al. described infections during the
course of SE and found an association between clinical short-term
outcome and infections.8 The occurrence of infections in that study
was high; 35.6%, and infections were associated with longer
duration of SE, greater risk of refractory SE, and higher mortality. In
the discussion, the authors prudently noted that the results might
be confounded by a high proportion of the cohort suffering from
acute symptomatic SE due to hypoxic-ischaemic encephalopathy, a
condition with detrimental prognosis. As this study was performed
in a single tertiary centre, it needs to be replicated in another
population. In Sweden, neurologists are typically not responsible
for the care or patients with hypoxic-ischaemic encephalopathy,
which presented an opportunity to investigate the incidence of
infections in a cohort with aetiologies of SE different to the cohort
described by Sutter et al. The aim of our study was therefore to
assess if these ﬁndings were valid also in a cohort of patients with
SE of less catastrophic aetiology, where optimal supporting care is
very important, since the prognosis of SE itself is substantially
better.served.
Table 1
Clinical features of SE and treatment. GCSE, generalized convulsive SE, FCSE, focal
convulsive SE, NCSE, non-convulsive SE. Refractory SE = continued or relapse within
24 h of seizure activity after two medications. Super-refractory SE = SE refractory to
24 h of anaesthesia.
Demographics
Gender n %
Female 55 53
Male 48 47
Age Years SD/range
Mean 55 19.5
Median 62 19–87
Clinical features n %
History of epilepsy 73 71
On AED at time of admission 71 69
Type of SE
GCSE 58 56
FCSE with impaired consciousness 33 32
FCSE without impaired consciousness 7 6.7
NCSE 5 4.8
Aetiology
Acute symptomatic 31 30
Brain trauma/surgery 6 5.8
CNS-infection 4 3.8
Cerebrovascular 3 2.9
Alcohol 3 2.9
Cryptogenic/other 15 15
Hypoxic-ischaemic 0 0
Remote 71 69
Uncontrolled epilepsy 38 37
Brain tumour 16 16
Cerebrovascular 13 13
Neurodegenerative 1 <1
Other/unknown 3 2.9
Severity of SE
Refractory SE 59 57
Super-refractory SE 26 25
Mechanical ventilation 48 47
Short-term outcome
Discharge home 71 69
Discharge to other provider 30 29
Death 2 1.9
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2.1. Design and setting
The study design was a retrospective observational cohort
study. All patients with SE during 5 consecutive years were
included. The study was performed at Uppsala University Hospital
in Sweden, a tertiary epilepsy centre, serving a population of
300,000 people for secondary care and 2,000,000 people for
tertiary care. The study was approved by the local ethics
committee in accordance with the standards laid down in the
1964 Declaration of Helsinki and waived the requirement for
informed consent.
2.2. Patients and data collection
We performed a search for all patients with a diagnosis of SE at
the Department of neurology at Uppsala University Hospital (ICD-
10 code G41) between 2008 and 2012. The initial search yielded
118 hits. The inclusion criteria were patients over 18 years that had
suffered SE according to the diagnosis made by the treating
physician. Exclusion criteria were insufﬁcient or inaccessible
medical records. Eight patients did not meet the inclusion criteria
due to erroneous coding (had not suffered SE or were under 18
years of age), three patients were excluded because of restricted
access to their medical records, and four record entries were
duplicates. The included cohort consisted of 103 patients. The
medical records were reviewed according to a predeﬁned
template. Data were anonymized prior to analysis.
2.3. Deﬁnitions
Assumed aetiology of SE, administered treatment, and presence
of infections were all based on the entries made in the medical
records by the treating physician. At our centre, we use an
operational deﬁnition of SE as seizures lasting more than 5 min,
or recurrence of seizure activity without recovery of consciousness
after a seizure. Refractory SE was deﬁned as continuous seizure
activity or relapse of seizure activity within 24 h after two
medications. Super-refractory SE was deﬁned as SE refractory to
24 h of general anaesthesia. Duration of SE was counted as the time
from onset to the ﬁrst day without seizure activity. If patients were
sedated without EEG-monitoring, the time was counted until
awakening from general anaesthesia without recurrence of seizure
activity. EEG was performed in 44/59 patients with medically
refractory SE and 5/5 patients with NCSE. Regarding infections, we
used the time limit speciﬁed by the Centre for disease control and
prevention (CDC) for surveillance purposes. Presence of an infection
was determined based on laboratory values and notes in the
medical records. Community-acquired infection was deﬁned as an
infection presenting within 48 h of admission. Nosocomial infection
was deﬁned as an infection presenting after 48 h after admission.
2.4. Statistical analysis
Demographic and clinical characteristics were described as
continuous or categorical variables as appropriate. Fisher’s exact
test was used for categorical correlations. Correlation between
infection and duration of SE was assessed using both Spearman’s
rank correlation and linear regression. In the correlation analyses,
we excluded patients with missing values rather than extrapolat-
ing data points. Duration of SE in patients with and without
infection was compared using the non-parametric Mann–Whitney
test. p-Values <0.05 were considered statistically signiﬁcant.
Statistical analysis was performed in GraphPad Prism version 5 for
Mac (Graphpad Software Inc.).3. Results
We ﬁrst characterized the cohort (Table 1). A total of 103
patients were included, with a slight female predominance. The
average age was 55 years and the two most common types of SE
were generalized convulsive SE or focal motor SE with impaired
consciousness. Seventy per cent of the patients had a history of
epilepsy, and all but two patients with such a history were on
antiepileptic drugs at the time of admission (69%).
The aetiology of SE was acute symptomatic in 30% of the
patients and remote in 70%. The two most common aetiologies in
the remote group were uncontrolled epilepsy (37%) and brain
tumours (16%). None of the cases in the cohort was attributed to
hypoxic-ischaemic encephalopathy. Considering severity, 57% of
the patients had medically refractory SE, and 25% of the cases were
super-refractory. A total of 47% received mechanical ventilation.
Regarding short-term outcome, only two patients (1.9%) in the
cohort died. The vast majority, 69%, were discharged home,
whereas the other patients were discharged to regional hospitals
or other care providers (e.g. nursing homes, rehabilitation
facilities, etc.). The standard treatment at our facility is a
benzodiazepine followed by phosphenytoin, and in refractory
cases sedation with propofol. This was followed in the majority of
cases (Table 2).
We then determined the incidence of infections in our cohort
(Table 3). A total of 23 patients (22%) suffered community-
acquired infections. The most common infections were pneumonia
and urinary tract infections (UTI). We detected a total of 29 cases
Table 2
Anti-epileptic drugs administered. Out of all 103 patients, 6 patients with
convulsive focal SE without impaired consciousness (epilepsia partialis continua)
were admitted from the outpatient clinic for dose-adjustment of the pre-existing
oral AEDs. For one patient that was transferred from another hospital information
regarding initial therapy was not available in the medical records.
Total population (n = 103) n %
Speciﬁc treatment for SE 96 93
Only altered dose of oral AED 6 5.8
Information missing 1 0.97
1st drug (n = 96)
Diazepam 78 81
Lorazepam 8 8.3
Phosphenytoin 5 5.2
Clonazepam 2 2.1
Propofol 1 1.1
Levetiracetam 1 1.1
Sodium valproate 1 1.1
2nd drug (n = 85)
Phosphenytoin 68 80
Alternative BZP 7 8.2
Levetiracetam 6 7.1
Sodium valproate 2 2.4
Carbamazepine 1 1.2
Propofol 1 1.2
1st anaesthetic agent (n = 49)
Propofol 49 100
2nd anaesthetic agent (n = 3)
Thiopental 3 100
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patients with a community-acquired infection, so in total 39
patients (38%) suffered any infection. The most common foci of
nosocomial infections were also the respiratory or urinary tracts.
About half of the total cohort received intravenously administered
antibiotics during their stay in hospital.
Finally, we analyzed statistical associations between presence
of any infection and clinical features of the SE. Patients that were
not discharged home and patients that had received mechanical
ventilation were signiﬁcantly more likely to have suffered an
infection (OR 2.705, 95% CI:1.14–6.44 and 3.344, 95% CI: 1.44–
7.79) respectively).The duration of SE was signiﬁcantly longer inTable 3
Infections, administered antibiotics and statistical analysis of association between
infection and clinical features.
Infections n %
Infection, any 39 38
Community-acquired 23 22
Respiratory tract 8 7.7
Urinary tract 7 6.8
Unclear septicaemia 5 4.9
Meningitis 3 2.9
Nosocomial 29 28
Respiratory tract 13 13
Urinary tract 11 11
Unclear septicaemia 4 3.9
Gastrointestinal tract 1 <1
Treatment
Antibiotics, any 52 50
Antibiotics, iv 52 50
Antibiotics, oral 9 8.7
Correlation analysis OR (infection) 95% CI p-Value
Not discharged home 2.705 1.14–6.44 0.028
Mechanical ventilation 3.344 1.44–7.79 0.0071
Medically refractory 1.879 0.822–4.30 ns
Superrefractory 4.722 1.83–12.2 0.0019
Duration of SE (days) Median Range p-Value
No infection 1 1–17
Infection 2.5 1–56 0.0021patients with an infection compared to those without an infection
(median SE duration of 1 and 2.5 days, respectively), and presence
of infection was statistically correlated to SE duration in a linear
regression analysis (p = 0.0071). Patients with super-refractory SE
were signiﬁcantly more likely to have suffered an infection (OR
4.722, 95% CI: 1.831–12.18), but no signiﬁcant association could be
detected between infections and medically refractory SE.
4. Discussion
We here characterized the incidence of infections in a cohort of
patients suffering SE at a tertiary referral centre for neurology in
Sweden. A previous study on this issue demonstrated an
association between infections and more complicated SE in a
cohort with high mortality, including patients with SE due to
hypoxic-ischaemic brain injury.8 We report that infections, both
community-acquired and nosocomial, in our cohort occurred at a
rate that was very similar to Sutter et al.8 The short-term outcome
in our cohort was substantially better, which most likely reﬂects
the different aetiologies of SE. Nonetheless, we could detect
statistically signiﬁcant associations between prolonged SE with
poor short-term outcome and presence of infection.
In Sweden, neurologists do typically not handle SE due to
hypoxic-ischaemic encephalopathy, and as expected our cohort of
patients differed substantially to that of Sutter et al. regarding
aetiologies. Uncontrolled epilepsy accounted for 37% of the cases in
our cohort (15% in Sutter et al.8) and we had no cases of hypoxic-
ischaemic encephalopathy (15% in Sutter et al.8). Accordingly, the
short-term outcome for our cohort was favourable in comparison,
with a mortality of only 1.9% (25.6% in Sutter et al.8).
Out of all patients, 38% had an infection during their stay.
Community-acquired infections occurred in 22% of the cases in our
cohort, and nosocomial infections in 28%; ﬁgures very similar to
those presented in Sutter et al.8 (35.6% in total, 22.5% infections
during SE). As expected, the respiratory and urinary tracts were
dominant foci. We also assessed the association between infec-
tions and clinical characteristics of SE. Infections were more
common in patients that were ultimately not discharged home, in
patients that received mechanical ventilation, and in patients with
super-refractory SE. Similarly, patients with a long duration of SE
were also more likely to have infections. Our ﬁndings indicate that
the association between severe cases of SE and infections described
by Sutter et al.8 are generalizable among SE patients.
Importantly, the retrospective nature of the study results in
important limitations. First of all, the diagnosis of SE relies on the
diagnosis made by the treating physician. At our centre, there is a
high availability of EEG; the vast majority of patients with
medically refractory SE (44 out of 59) underwent EEG, as did all
patients with a diagnosis of non-convulsive SE (n = 5). Nonetheless,
the inclusion of patients in the study rests heavily on the diagnosis
made by the treating physician. Additionally, SE duration had to be
extrapolated from the medical records and approximated to the
ﬁrst day without general anaesthesia. It would have been very
interesting to perform multivariate analyses and search for
predictors of infections, such as age, type of SE, etc. However,
since data were not prospectively collected for the purpose of
research, we could only extract data, which are reasonably reliable
also in retrospect (infections, pre-existing epilepsy, drugs admin-
istered). Important variables that might affect both SE and
infections, such as a pre-existing neurological deﬁcit is not always
noted in the medical records in an acute setting, so in absence of
such important variables, multivariate analysis was deemed
inappropriate. Identifying clinical variables that can predict a
high risk of infections in SE should be a priority for future
prospective studies.
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NCSE in our cohort was low, which reﬂects the nature of our
neurology service. Neurologists in Sweden are typically not
responsible for patients with hypoxic-ischaemic encephalopathy
after cardiac arrest. The cohort did therefore not consist of ICU
patients with continuous EEG-monitoring, which would most
likely have resulted in a much higher number of NCSE, but rather
patients admitted from regional hospitals or the local emergency
department with a clinical suspicion of seizure activity.
There are differences between our data and Sutter et al.8 that
are worth highlighting. In their statistical analyses, Sutter et al.8
differentiated between patients whose infections were present
before SE and those that were diagnosed during SE regarding short-
term outcome. Because of the limited size of our material – only 10
patients had community acquired infections without suffering a
later nosocomial infection – and because of the retrospective
nature of our data which did not clearly allow for an exact time of
SE cessation, we did not differentiate between the two groups in
our analysis. In Sutter et al.8, signiﬁcant differences in short-term
outcome and SE duration were demonstrated between patients
without infections and patients with infections diagnosed during
SE. The majority of our patients with infections (29/38) suffered
from nosocomial infections, so our ﬁndings are well in line with
those of Sutter et al8. The ﬁndings in our study are also congruent
with previous reports of an association between ventilation and
higher in-hospital death rate in patients with SE and a fourfold
increase in nursing resources and signiﬁcant prolongation of ICU
stay.9
The implications of the association demonstrated in this and
previous studies are complex, as causation regarding the severity
of SE aetiology and infection is probably not unidirectional.
Infections and fever can exacerbate seizures, but hypoventilation,
aspiration, ICU-care, and a number of other factors in patients with
SE of more severe aetiology might plausibly enhance their
vulnerability for infections. It is also likely that severe neurological
deﬁcits that prevent independent living affect both our short-term
outcome measure and susceptibility to infection, so our data must
be interpreted in a purely observational rather than causative
manner. The most important ﬁndings in our study is not the
association between infections and duration or short-term
outcome of SE, which has already been established, but rather
that this association seems to extend also to patients with SE of less
severe aetiology than those described in the previous studies.The ﬁndings highlight the need for vigilant preventive
measures and prompt treatment of nosocomial infections in
patients with SE, especially in the ICU. The association between
mechanical ventilation and infections also raises the important
question of optimal use of ICU resources in SE. Future studies will
hopefully determine which cases of SE are likely to beneﬁt from
general anaesthesia and mechanical ventilation and the optimal
length of that therapy, so that other patients might be spared
associated risks of infection.
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